At least seven biotechs and pharmas are slated to report earnings this week. 3Q12 EPS for Cubist Pharmaceuticals Inc. (NASDAQ:CBST) is expected to jump by 36%, while quarterly EPS for Forest Laboratories Inc. (NYSE:FRX) is